ArticleThe Journal of pharmacology and experimental therapeutics2025
VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis.
Shelby Waddell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it